News

Regular Monthly Dividends Announced by Financial 15 Split Corp.

Regular Monthly Dividends Announced by Financial 15 Split Corp.

Financial 15 Split Corp. Announces Monthly Dividend

Financial 15 Split Corp. (TSX: FTN) is pleased to announce a regular monthly dividend distribution. Each Class A share will receive $0.12570 per month, amounting to an annual yield of $1.51. For Preferred shares, the distribution is set at $0.07083 monthly, translating to an annual payout of $0.850. These distributions are scheduled to be paid on a date that aligns with shareholder records. Shareholders holding shares as of the specified record date will be eligible for these dividends.

Historical Performance of Dividend Payments

Since the inception of its investment strategy, Class A shareholders have enjoyed a cumulative total of $27.44 per share. Meanwhile, Preferred shareholders have received a total of $12.62 per share. This impressive cumulative distribution reflects the ongoing commitment of Financial 15 Split Corp. to deliver value to its investors, bringing the combined total to $40.06 per share for both classes of shareholders.

Investment Strategy Overview

Financial 15 Split Corp. strategically invests in a high-quality portfolio consisting of fifteen well-rated financial services companies across Canada and the U.S. The portfolio includes prominent financial institutions such as Bank of Montreal, The Bank of Nova Scotia, and the Royal Bank of Canada. Other notable companies within the portfolio are Manulife Financial Corporation, Sun Life Financial, and several major U.S. banks, including Goldman Sachs and JP Morgan Chase & Co. This diversified investment strategy is designed to provide stability and growth potential for shareholders.

Details Surrounding September Distribution

As the scheduled payment date approaches, investors are encouraged to stay informed about the details surrounding these distributions. The expectation is that the distributions will reflect the solid earnings and overall performance of the underlying portfolio. It is always advisable for shareholders to ensure that they meet the criteria for record dates to receive their respective dividends smoothly.

Contacting Investor Relations

For any inquiries regarding the investment or the upcoming dividend distribution, investors can reach Financial 15 Split Corp. at their toll-free investor relations number. Local callers may use the dedicated phone line for assistance. Their official website serves as a resource for further information regarding portfolio updates and other corporate announcements.

Frequently Asked Questions

What is Financial 15 Split Corp.?

Financial 15 Split Corp. is an investment company that focuses on investing in a portfolio of high-quality financial services companies.

How much is the monthly dividend?

The monthly dividend for Class A shares is $0.12570, while Preferred shares receive $0.07083.

When is the dividend payable?

The dividends are payable on a date specified usually following the record date.

What is the record date for the dividends?

The record date is generally set a few days before the payable date, and shareholders must hold their shares by this date to receive dividends.

Who can I contact for more information?

Investors can contact Financial 15 Split Corp. through their investor relations hotline or visit their official website for detailed information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ZEISS Expands in China: Tackling Myopia's Surge

Updated Category News Views 157

ZEISS Sets Sights on China’s Myopia Epidemic They're calling myopia a public health crisis in China, and if you've seen the statistics, that's no exaggeration. Enter ZEISS Medical Technology, angling for a piece of the pie with their newly NMPA-approved PT LUNANA phakic intraocular lens. This is more than just another medical product, folks. It's a strategic entry into...

Continue Reading
Keenova Q3 2026: Net Sales Up, Losses Shrink

Updated Category News Views 29

A Strong Quarter Despite Some Knocks It ain't every day you see a company like Keenova Therapeutics clocking solid top-line growth, despite battling the waves of operational losses. Now, don't get me wrong; I ain't swooning over their near $96 million loss from continuing operations, but let me give credit where it's due—those sales numbers popped impressive. Pillars of...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 109

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Grandparents' Holiday Gift Picks: Expertly Tested Ideas

Updated Category News Views 21

Hunting for the Perfect Gift? Look No Further The holiday hustle and bustle inevitably sparks one of the annual dilemmas: What on earth should you buy those grandkids of yours? No need to get all twisted up this season. Enter ZestYears, the savvy go-to guide for grandparents who want to nail gift-giving without breaking a sweat or the bank. These folks, based out of...

Continue Reading
Kelley Blue Book Hits 100: Celebrating on Route 66

Updated Category News Views 36

If you've ever punched numbers on car values, you've probably bumped into Kelley Blue Book. This icon in vehicle valuation is marking its 100th birthday with a bang—road-tripping across Route 66 to sprinkle some joy across the dusty roads of history. Nostalgia Meets the Open Road The legendary Route 66 is not just the backdrop but the beating heart of this centennial...

Continue Reading
Tampa General Tackles Housing with The Linden Launch

Updated Category News Views 93

Building Bridges Between Work and Home Well, it’s about time someone threw in a lifeline to those drowning in Florida’s housing crisis. Tampa General Hospital, teaming up with The Michaels Organization, is setting the stage with 'The Linden': a solution pitched smack dab into the heart of affordability woes. This isn't your run-of-the-mill press release fluff. They've...

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 24

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Caladan and NextBlock's Move Expands Crypto Liquidity

Updated Category News Views 55

Partnership to Expand Digital Asset Liquidity Looks like Caladan and NextBlock just threw their hats in the ring to shake up South Korea’s institutional digital asset market. These two big guns have cooked up a strategic collaboration, aiming to bring more global liquidity into the mix. Dive into what this means for the digital asset scene in South Korea. Why This Move...

Continue Reading
Giti Tire Hits Jaw-Dropping Speeds with Record-Breaker

Updated Category News Views 78

Blazing a New Trail in Automotive Excellence Who would've thought rubber on road could hit a jaw-dropping 503.17 km/h (312.65 mph)? Giti Tire just broke the mold, etching its name into the history books with the Guinness World Records™ title for their GitiSport e.GTR2 Pro tires. This isn't just about speed—it's about engineering marvel and pushing boundaries in...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 81

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Cresco Labs: A Unique Investment Opportunity

Updated Category News Views 158

Assessing Cresco Labs: A Promising Investment Prospect With the cannabis market continuing to evolve, Cresco Labs Inc. stands out as an intriguing option for investors. Despite a backdrop of flat earnings and ongoing market challenges, analysts emphasize that Cresco (CRLBF) is holding the line as an "Overweight" stock. A recent analysis reveals Cresco's substantial...

Continue Reading
Context Therapeutics' First Quarter 2025 Results and Updates

Updated Category News Views 249

Context Therapeutics Releases First Quarter 2025 Financial Results Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, made significant strides in Q1 2025, especially with its two product candidates, CTIM-76 and CT-95, currently in Phase 1 clinical trials. As of March 31, 2025, the company reported...

Continue Reading
Capricor's Challenges: FDA Review Delays and Legal Woes

Updated Category News Views 70

Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...

Continue Reading
Breaking New Ground: Wood Partners Launches Alta Flatirons

Updated Category News Views 258

Wood Partners Begins Construction on Alta Flatirons The 251-unit apartment community is one of the last remaining parcels of the Downtown Superior Masterplan. Overview of Alta Flatirons National multifamily developer Wood Partners has officially commenced the development of Alta Flatirons, a significant project located in a suburb near Boulder. This community, which will...

Continue Reading
Adobe Unveils New AI Tools to Maximize Content Engagement

Updated Category News Views 86

Adobe Unveils Exciting New AI-Driven Marketing Tools Adobe Systems Incorporated (NASDAQ: ADBE) has just rolled out a game-changing suite of updates to its Adobe Experience Cloud services. These innovations are designed to help brands enhance the performance of their AI-generated marketing content significantly. With a focus on advanced analytics and the ability to...

Continue Reading